Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.

The present study was designed (a) to characterize the activity of loxiglumide as a peripheral cholecystokinin (CCK) antagonist in healthy human subjects, and (b) to determine whether CCK is a physiologic regulator of the intestinal phase of meal-stimulated exocrine pancreatic and biliary secretions...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Hildebrand, P, Beglinger, C, Gyr, K, Jansen, J B, Rovati, L C, Zuercher, M, Lamers, C B, Setnikar, I, Stalder, G A
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 1990
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC296477/
https://ncbi.nlm.nih.gov/pubmed/2312719
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak